You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
10 July 2026 - Accord BioPharma, the US specialty division of India-based Intas Pharmaceuticals Ltd, focused on the development of oncology, immunology, and central nervous system (CNS) therapies, announced on Thursday that the US Food and Drug Admin...
10 July 2026 - Swedish cancer diagnostics company BiBBInstruments AB (Spotlight Stock Market: BIBB) said on Thursday it has signed its first European commercial distribution agreement for its powered endoscopic biopsy system EndoDrill GI with Europea...
9 July 2026 - Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd (NYSE: and TASE: TEVA), announced on Thursday that it has entered into a global licensing agreement with biopharmaceutical company Polpharma Bio...
9 July 2026 - Biotechnology company Ionis Pharmaceuticals Inc (Nasdaq:IONS) and its partner AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) reported on Thursday that the Phase 3 CARDIO-TTRansform trial of eplontersen in adults with transthyretin-media...
9 July 2026 - Northwest Biotherapeutics (OTCQB:NWBO)(NWBio), a biotechnology company developing DCVax personalised immune therapies for solid tumour cancers, announced on Wednesday that the company's chief technical officer, Dr. Marnix Bosch, pr...
9 July 2026 - Lynk Pharmaceuticals Co Ltd, a clinical-stage innovative drug development company focused on immune and inflammatory diseases, announced on Wednesday that the first patient has been successfully dosed in the Phase II clinical trial eval...
9 July 2026 - Taiwan-listed clinical-stage biotech HanchorBio Inc (TWSE:7827) announced on Wednesday that it is looking to broaden the development path for HCB101, its lead oncology asset, through a new partnership.HanchorBio's subsidiary, FBD B...